DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer.
- DOI
- 10.1158/1078-0432.ccr-25-0874
- Published
- 2026-03-01
- Container
- Clin Cancer Res
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-25-0874,
title = {DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer.},
author = {Jhaveri K and Loi S and Hamilton E and Schmid P and Anders CK and Testa L and Wildiers H and Tseng LM and Lu YS and Park YH and Im SA and Chen SC and Young RR and Lloyd C and Wrona M and Zhang C and Carroll D and André F.},
year = {2026},
journal = {Clin Cancer Res},
doi = {10.1158/1078-0432.ccr-25-0874},
url = {https://doi.org/10.1158/1078-0432.ccr-25-0874}
}RIS
TY - JOUR TI - DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer. AU - Jhaveri K AU - Loi S AU - Hamilton E AU - Schmid P AU - Anders CK AU - Testa L AU - Wildiers H AU - Tseng LM AU - Lu YS AU - Park YH AU - Im SA AU - Chen SC AU - Young RR AU - Lloyd C AU - Wrona M AU - Zhang C AU - Carroll D AU - André F. PY - 2026 JO - Clin Cancer Res DO - 10.1158/1078-0432.ccr-25-0874 UR - https://doi.org/10.1158/1078-0432.ccr-25-0874 ER -
APA
K, J., S, L., E, H., P, S., CK, A., L, T., H, W., LM, T., YS, L., YH, P., SA, I., SC, C., RR, Y., C, L., M, W., C, Z., D, C., & F., A. (2026). DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer.. Clin Cancer Res. https://doi.org/10.1158/1078-0432.ccr-25-0874
Source records
- europe-pmc · retrieved 2026-09-27T05:04:29.094Z